目的构建并鉴定再生基因4(regenerating islet-derived family member 4,RegⅣ)短发夹干扰RNA(short hairpin RNA,shRNA)慢病毒载体,继而建立稳定干扰RegⅣ基因表达的胰腺癌细胞株PANC-1。方法使用聚合酶链式反应(polymerase chain reac...目的构建并鉴定再生基因4(regenerating islet-derived family member 4,RegⅣ)短发夹干扰RNA(short hairpin RNA,shRNA)慢病毒载体,继而建立稳定干扰RegⅣ基因表达的胰腺癌细胞株PANC-1。方法使用聚合酶链式反应(polymerase chain reaction,PCR)检测RegⅣ基因在胰腺癌细胞株中的表达情况。构建重组靶向干扰RegⅣ基因的shRNA慢病毒表达质粒pGC-shRNA-RegⅣ,用脂质体转染的方法将载体导入胰腺癌细胞,建立稳定表达shRNA的细胞株。使用荧光定量PCR检测干扰效率。RegⅣ基因过表达载体的构建方法为:将获取的目的基因与pEGFP-RegⅣ-3FLAG过表达质粒载体分别进行双酶切,利用电泳回收双酶切产物,转化感受态细胞并进行测序验证,验证成功后,使用Western blot检测其在293T细胞中的表达强度。结果 PCR结果显示RegⅣ在PANC-1中表达最高,在BxPC-3中表达最低。测序验证pGC-shRNA-RegⅣ重组质粒构建成功。将重组质粒稳定转染入胰腺癌细胞株PANC-1后能明显抑制RegⅣmRNA表达水平。过表达载体pEGFP-N1-3FLAG-RegⅣ合成成功后进行Western blot鉴定,验证pEGFP-N1-3FLAG-RegⅣ过表达载体构建成功。过表达RegⅣ基因转染BxPC-3后,与空质粒组相比,RegⅣ表达量明显提高。结论成功建立了靶向稳定干扰RegⅣ基因表达的shRNA胰腺癌细胞株PANC-1。展开更多
Objective： To construct a lentiviral expression vector for RNA interference （RNAi） of human VIM gene; and assess its gene silencing effect in pancreatic cancer cell line Panc-1. Methods： Three pairs of human VIM g...Objective： To construct a lentiviral expression vector for RNA interference （RNAi） of human VIM gene; and assess its gene silencing effect in pancreatic cancer cell line Panc-1. Methods： Three pairs of human VIM gene short hairpin RNA（shRNA） sequences were designed using a software available on-line and one pair came from document. After synthesis and annealing, four double-stranded oligonucleotides （dsOligo） were cloned into the pGCL-GFP/U6 plasmid, which were subsequently confirmed by polymerase chain reaction （PCR） and DNA sequencing analysis. Real-time PCR and Westemblotting were used to screen the effective pGCL-GFP-shRNA plasmid in 293T cells, then the most effective one was packed into the recombinant lentivirus Lv-VIM-shRNA with lentiviral packing materials pHelper 1.0 and pHelper 2.0 in 293T cells. The titer of lentivirus was determined by hole-by-dilution titer assay. The silencing effect of Lv-VIM-shRNA in Panc-1 calls were validated by real-time PCR and Western-blotting. Results： An effective Lv-VIM-shRNA was successfully constructed. The titer of lentivirus was determined on 2× 10^9TU/mL. The expressions of VIM mRNA and vimentin were down-regluated in the Panc-1 cells infected with Lv-VIM-shRNA. Conclusion： An effective Lv-VIM-shRNA could inhibit the expression of VIM gene in Panc-1 cells in vitro, which provides a tool for investigating the role of VIM gene in the signaling pathway involved in tumorigenesis and progression of pancreatic cancer and searching new therapeutic targets.展开更多
基金Supported by a grant from the National Natural Science Foundation of China （No. 30600592）.
文摘Objective： To construct a lentiviral expression vector for RNA interference （RNAi） of human VIM gene; and assess its gene silencing effect in pancreatic cancer cell line Panc-1. Methods： Three pairs of human VIM gene short hairpin RNA（shRNA） sequences were designed using a software available on-line and one pair came from document. After synthesis and annealing, four double-stranded oligonucleotides （dsOligo） were cloned into the pGCL-GFP/U6 plasmid, which were subsequently confirmed by polymerase chain reaction （PCR） and DNA sequencing analysis. Real-time PCR and Westemblotting were used to screen the effective pGCL-GFP-shRNA plasmid in 293T cells, then the most effective one was packed into the recombinant lentivirus Lv-VIM-shRNA with lentiviral packing materials pHelper 1.0 and pHelper 2.0 in 293T cells. The titer of lentivirus was determined by hole-by-dilution titer assay. The silencing effect of Lv-VIM-shRNA in Panc-1 calls were validated by real-time PCR and Western-blotting. Results： An effective Lv-VIM-shRNA was successfully constructed. The titer of lentivirus was determined on 2× 10^9TU/mL. The expressions of VIM mRNA and vimentin were down-regluated in the Panc-1 cells infected with Lv-VIM-shRNA. Conclusion： An effective Lv-VIM-shRNA could inhibit the expression of VIM gene in Panc-1 cells in vitro, which provides a tool for investigating the role of VIM gene in the signaling pathway involved in tumorigenesis and progression of pancreatic cancer and searching new therapeutic targets.
基金the National Natural Science Foundation of China,No.81072140,81172477the Medical Engineering Interdisciplinary Project of Shanghai Jiao Tong University,No.YG2013MS67,YG2014QN11~~
